Semaglutide and tirzepatide have both shown great promise as medicines for medical weight loss by suppressing appetite and helping promote weight loss. Both belong to the class of drugs known as GLP-1 receptor agonists (GLP-1 RAs), with mechanisms of action designed to regulate energy balance. With CMS, you can look and feel your best with the latest, most advanced cutting-edge medical treatments. Anti-aging, Hormone Replacement Therapy (HRT), Sexual Wellness, Peptides, TRT, Pain Therapy, Shockwave, Semaglutide Medical Weight Loss.
Semaglutide, an GLP-1 receptor agonist (RA), has been approved by regulatory agencies for the treatment of obesity. Administered as an subcutaneous injection, Semaglutide works by mimicking the action of GLP-1 hormone released by food intake; GLP-1 helps regulate appetite and satiety by signaling to brain to reduce food intake while slowing gastric emptying; this effect ultimately leads to decreased hunger feelings, leading to reduced caloric intake, leading to weight loss. Semaglutide affects GLP-1 receptors within central nervous system interactions involving GLP-1 receptors located there – all these effects happen through GLP-1 receptor interactions involving GLP-1 receptors present there as well as interactions with GLP-1 receptors present there as well.
Are you ready to optimize your health and take your well-being to the next level? Our comprehensive health optimization eBook is here to guide you on your journey towards better health. And for a limited time, we have a special offer just for you! Don’t miss out on this opportunity to transform your health and unlock your full potential. We have a 94% success rate. Serving clients nationwide.
Tirzepatide, like semaglutide, is another GLP-1 receptor agonist (RA). Both medications can be given through subcutaneous injections. Tirzepatide’s dual mechanism of action involves stimulating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously; this helps improve regulation of glucose metabolism while simultaneously suppressing appetite. GIP helps modulate food intake to improve glycemic control. By activating these receptors simultaneously, tirzepatide may contribute to decreased appetite, decreased caloric intake, and weight loss.
Our medical weight loss programs provide semaglutide and tirzepatide to those diagnosed with obesity or overweight and who have not seen adequate results through lifestyle modifications alone. These medications should be used as supplements to a comprehensive weight-loss plan that includes diet and physical activity modifications as well as behavioral therapy. These medications should only be taken under the direction of a qualified healthcare provider who specializes in weight management, with dosage tailored specifically to an individual patient’s individual needs and medical history. Lifestyle changes remain integral components of any successful weight loss program – speak to us about CMS or FLOA programs to see how we make an impactful difference to the lives of our clients!